EUVIMEDOpdag EUVIMED
Vergleichsstudie

Combined Multiorgan Heart and Kidney Transplants With Single Donor Allografts: Simultaneous Versus Staged?

Jacqueline I Kim iD, Suhani S Patel iD, Nader Moazami iD, Jeffrey M Stern iD, Dorry L Segev iD, Allan B Massie iD

Clinical Transplantation · 2026

DOI: 10.1111/ctr.70400 ↗

At a glance

Vergleichsstudie in Clinical Transplantation, 2026. Written by Jacqueline I Kim and 5 co-authors. Institution: Department of Surgery, Transplant Institute, NYU Langone Health, New York, New York, USA. Major MEDLINE topics: Heart Transplantation, Kidney Transplantation, Tissue Donors, Graft Rejection. 15 references. Funded by: NIAID NIH HHS, NIDDK NIH HHS, National Institute of Allergy and Infectious Diseases.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

Multiorgan heart and kidney transplants (HKTx) performed for patients with end‐stage heart failure and chronic kidney disease have increased in recent years. However, no established protocols exist on whether a heart and kidney from the same donor should be transplanted in the same operation versus 1–2 days apart.

Methods

Using SRTR data 1993–2023, we compared same‐donor HKTx recipients with both transplants performed on the same day (“simultaneous”) to recipients with kidney transplants performed within 1 day of the heart transplant (“staged”). We examined differences in weighted post‐transplant clinical characteristics using average treatment effect. Post‐transplant mortality and graft failure was also assessed using Kaplan–Meier curves and instrumental variable analysis adjusted for recipient characteristics and year of transplant.

Results

The proportion of staged HKTx increased from 20.7% in 2015 to 58.8% in 2023. Recipients of simultaneous versus staged HKTx had similar rates of stroke (3.4% vs. 4.1%, p = 0.3), permanent pacemaker prior to discharge (2.0% vs. 1.8%, p = 0.7), and kidney primary non‐function (2.7% vs. 2.6%, p = 0.8). However, simultaneous HKTx recipients had shorter kidney cold ischemic time (median (IQR) (h) 10.0 (7.5 vs. 14.6) versus 20.3 (15.9, 24.8), p < 0.001) and a lower weighted hospital stay compared to staged HKTx recipients ( 1.08 1.09 1.11 , p < 0.001). Weighted patient mortality, all cause heart failure (ACHF), and all cause kidney failure (ACKF) 4 years post‐transplant were slightly lower for simultaneous versus staged HKTx recipients (17.1% vs. 19.9%, 17.2% vs. 20.1%, 20.8% vs. 24.7%). However, instrumental variable analysis found no meaningful differences in adjusted patient survival, ACHF, or ACKF by HKTx type.

Conclusion

Simultaneous HKTx recipients have shorter hospital stays, decreased mortality, and higher rates of graft survival post‐transplant compared to staged HKTx recipients, which may reflect favorable patient factors that enable both operations to be performed on the same day rather than an inherent benefit of simultaneous HKTx, given equivalent adjusted patient mortality, ACHF, and ACKF.

Subjects

MeSH terms (MEDLINE)

Heart TransplantationKidney TransplantationTissue DonorsGraft RejectionHeart FailurePostoperative ComplicationsKidney Failure, ChronicHumansFemaleMaleGraft SurvivalFollow-Up StudiesMiddle AgedPrognosisRisk FactorsSurvival RateRetrospective StudiesAllograftsGlomerular Filtration RateAdultKidney Function Tests

Author keywords

graft survivalheart (allograft) function/dysfunctionkidney (allograft) function/dysfunctionorgan perfusion and preservationpatient characteristics

Authors and institutions

  • Department of Surgery, Transplant Institute, NYU Langone Health, New York, New York, USA.
  • Department of Cardiothoracic Surgery, NYU Langone Health, New York, New York, USA.
  • Scientific Registry of Transplant Recipients, Minneapolis, Minnesota, USA.

ORCID profiles: Jacqueline I Kim, Suhani S Patel, Nader Moazami, Jeffrey M Stern, Dorry L Segev, Allan B Massie

Funding

  • NIAID NIH HHS
  • NIDDK NIH HHS
  • National Institute of Allergy and Infectious Diseases
  • National Institute of Diabetes and Digestive and Kidney Diseases

Cite

APA

Kim, J. I., Patel, S. S., Moazami, N., Stern, J. M., Segev, D. L., & Massie, A. B. (2026). Combined Multiorgan Heart and Kidney Transplants With Single Donor Allografts: Simultaneous Versus Staged?. Clinical Transplantation. https://doi.org/10.1111/ctr.70400

Vancouver

Kim JI, Patel SS, Moazami N, Stern JM, Segev DL, Massie AB. Combined Multiorgan Heart and Kidney Transplants With Single Donor Allografts: Simultaneous Versus Staged?. Clinical Transplantation. 2026. doi:10.1111/ctr.70400

BibTeX
@article{Kim2026,
  author = {Kim, Jacqueline I and Patel, Suhani S and Moazami, Nader and Stern, Jeffrey M and Segev, Dorry L and Massie, Allan B},
  title = {Combined Multiorgan Heart and Kidney Transplants With Single Donor Allografts: Simultaneous Versus Staged?},
  journal = {Clinical Transplantation},
  year = {2026},
  doi = {10.1111/ctr.70400}
}
Start for free →